35
KJM5230-H04 KJM5230 - Biologisk aktive molekyler urset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper g bioaktive naturstoffer. mnet omhandler syntese/biosyntese, virkningsmekanisme, biotilgjengelighet og tabilitet for utvalgte stoffklasser. truktur-aktivitets forhold og strukturoptimalisering inngår også i kurset.

KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

Embed Size (px)

Citation preview

Page 1: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

KJM5230 - Biologisk aktive molekyler

Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer.

Emnet omhandler syntese/biosyntese, virkningsmekanisme, biotilgjengelighet og stabilitet for utvalgte stoffklasser. Struktur-aktivitets forhold og strukturoptimalisering inngår også i kurset.

Page 2: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

LærebokD. A. Williams; T. L. Lemke. “Foye’s Principles of Medicinal Chemisrty” 5th Ed.LippincottWilliams&Wilkins., Philadelphia, 2002. ISBN 0-683-30737-1

PensumGenerell del – Part l:

Overwiev + Kap. 1-2; 4-5; 7-8:

Spesiell del – Part II.

Sect. 6 Chemotherapeutical Agents:kap 34-39:

•Natural Products•Drug Design•Reseptors - Drug Action•Pysichemical/Biopharmaceut. Properties•Drug Metabolism

•Antibiotics/Antimicrobial Agents•Antiparasitic Agents•Antifungal Agents•Antimycobacterial Agents•Anticancer Agents•Antiviral Agents

Page 3: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Origin of Drugs / Bioactive Compounds

•Natural Products / Natural Product Derivatives

•Random testing, serendipity

•Screening of Libraries

•(Rational) Drug Design (1. mentioned SciFinder 1970, most papers after 1990)

•Screening/Design/Serendipity •Lead compound -•Design/Structure Optimisation•Actual Drug

Why new drugs?ResistanceNew diseases (Aging, life style)Less tollerance for side effects

•Activity•Toxicity•Bioavailability•Metabolism

in vitroin vivo animalsin vivo humans

Page 4: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Origin of Drugs / Bioactive Compounds: HistoryBefore 1800: Plants, plant extracts, inorganic material

1805: Morphine isolated from opium (sructure proposed 1935, prooved by synth. 1952)

1828: First organic synthesis (urea)

1840-1850: First synthesized org. compds used in medicine: CHCl3, Et2O anestechia)

Ex of early synthetic drugs:Choral hydrate (sleeping pill) 1869Acetyl salicylic acid synth 1853, clin trials 1893Phenazone synth 1884Benzocaine 1902Prontocil 1932

Ex of early isolated nat. prod.Quinine ca 1825Digitoxin 1841 (structure 1928)Salicylic acid, antipyretic 1875Cocaine isol. 1860, local anestethic 1884Benzylpenicillin 1941

Traditional medicineScreeningSerendipity

Page 5: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Origin of Drugs / Bioactive Compounds

•Natural Products / Natural Product Derivatives

•Random testing, serendipity*

•Screening of Libraries

•(Rational) Drug Design (1. mentioned SciFinder 1970, most papers after 1990)

•Screening/Design/Serendipity •Lead compound -•Design/Structure Optimisation•Actual Drug

Why new drugs?ResistanceNew diseases (Aging, life style)Less tollerance for side effects

•Activity•Toxicity•Bioavailability•Metabolism

in vitroin vivo animalsin vivo humans

*Fortunate discovery by accident“The three princes of Serendip” Persian Fairy tailSerendip=Sri Lanka

Page 6: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Natural Products

•Only source of drugs before last part of 19th century•Antibiotics 1940 - 1960•Cyclosporin (immunomodulator) isolated from soil fungus Hardangervidda 1971•Taxol isolated 1960s, approved drug USA 1992

O

OHO

NH

O O O

O

OH

OO

O

OO

•Lead compounds HydrophilicAminogroup(can be protonated)

Spacer-Cn-X-X: -CO2- -CONH- -NHCO-

Lipophilic(Aryl)N

CO2Me

O

OCocaine

O

O

N

NH2

Procaine (1905)

NH

N

Lidocaine/Xylocaine(1946)

O

Acid labile ester

Page 7: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Natural Products

Sources•Microorganisms (bacteria, fungus) - Antibiotics

•Higher plants, ex. morphine, quinine, taxol

•Sponges (polycellular “animals”, no real organs or cell tissue) ex. agelasines

•Higher animals, fewer examples, epibatidine from South American tree frog

Microorganisms, sponges, plants

No immune system, produce their own antibiotics as defence

Secondary metabolites with great structural diversity, stereochemistry!

Secondary metabolites have no known metabolic role in cells

Three main classes: alkaloids, terpenoids, phenolics

HN

N

Cl

Epibatidinepainkiller, toxic!potent inhibitor of certain nicotinic reseptors

N N

Nicotine

Page 8: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Alkaloid Natural Products

•Largets class of secondary metabolites, >6500 compds known•Contains N, most compds basic (alkaline)•Often highly toxic•Found in certain higher plants (seldom in bacteria)•Little is known regarding why alkaloides are produced•Biosynthesis from amino acids

Page 9: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Sub types cholinerge reseptors

NicotinergeMuscarinerge

NO

O

O H

ca. 5Å

OH

N

NHO

H

O

HO

NSourceAmanita muscaria

Nicotine fromNicotiana tabacum

Acetylcholine

CNS

Effektor celle

Reseptor

Synapse

Acetylkolin

Noradrenalin

Det somatiske nervesystem Det autonome nervesystem

CNS CNS

Det sympatiskenervesystem

Det parasympatiskenervesystem

ganglion

Alkaloid Natural ProductsAmino alkaloids: N as amine / amide (not in heterocycle)

Source Ephedra sinica

O

HO

N

(+) Muscarine

HN

OH

(-)Efedrin

Biosynth from phenylalanine

NH2

CO2H

Bioactivity ≈ Adrenaline (Epinephrine) only weaker

HN

OHHO

HO

Page 10: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Alkaloid Natural Products

Amino alkaloids

NH2

Mescaline

Biosynth from thyrosine

NH2

CO2HHO

MeO

MeOOMe

SourceLophophora williamsi

Pyridine / piperidine alkaloids

N

N

Nicotine

N

O

O

O

O

Cocaine

Isolert fraErythroxylon coca

N

tropane

(8-methyl- 8-azabicyclo[3.2.1]octane)

Page 11: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Parasympatolytika(Antikolinergika)

Tropanalkaloider

N

tropan

Atropa belladonna

Hyoscamus niger(bulmeurt)

Isolert fra Atropa belladonna og Hyoscamus niger

Esterhydrolyse også mulig i basisk miljø

N

O

O

OH

(±) Atropin

Base

N

O

O

OHH

α =til C O

(-) Hyoscyamin

NO

O

OH

ca. 5Å

"N"O

O

R

R>Me"N": kvart el. tert (protoner. in vivo)

ca. samme avst. som AcCh

Gen. blokker

Relaksering av tarmmuskel, pupillutvidelse

Scopolamin

Mer CNS dempende enn atropinreisesykeplasterkarmpeløsendepupilutvidendeberoligende“sanhetsserum”

N

O

O

OHH

Oracimisationbase

Ester hydrol.

N

O

OHHO HO

OH

Skopin Tropasyre

+

NHO

O

Skopolin

Pyridine / piperidine alkaloids

Page 12: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Semisyntetiske tropanalkaloider

N

O

O

OH

Atropin

N

O

O

OH N

O

OH

N

NO

O

OH

ca. 5Å

"N"O

O

R

R>Me"N": kvart el. tert (protoner. in vivo)

ca. samme avst. som AcCh

Gen. blokker

Homatropin Tropikamid

øyedr.korterevirketid

Alkaloid Natural Products

Pyridine / piperidine alkaloids

Page 13: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Alkaloid Natural Products

Curare - Pilgift - Søramerikanske indianereBland. Av flere alkaloider med muskeslammende effektFlere plantekilder bl.a. Chondodendron tomentosum

Isoquinoline alkaloids

CNS

Effektor celle

Reseptor

Synapse

Acetylkolin

Noradrenalin

Det somatiske nervesystem Det autonome nervesystem

CNS CNS

Det sympatiskenervesystem

Det parasympatiskenervesystem

ganglion

MeON

Me

MeO

MeONH

Me

MeO

MeO

MeO

MeO

MeO

MeO

OMe

O

OO

O

MeO

O

HO

OOH

OMe

NR

Me

NMe

Me

R=H: TubocurarinR=Me: Wrong struct.

N N

Ex. Mivacurium kloridMuscle relax, anesthesia

Cl

NO

ON

O

O

Cl

Esterase

Cl

NOH

HON

O

O

Cl

HOOH

Succinsyrekolin

Suksametonium, Curacit® “Nesset”

Page 14: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Alkaloid Natural ProductsIsoquinoline alkaloids

Morfin isolert fra opium 1803 (Morpheus: gresk søvngud)

O OHHO

N

OOHHO

N

Morfin

O

OHN

OH

H2N

OH

HN H

NO

OO

NH

HO

NH

O

O

S

Met-enkefalin

Tyr N-terminalhos opiopeptider

Morfinanalogs, binds to opiopeptide (endorfin / enkefalin) reseptors

Derivative of phenantrene

Page 15: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Naturally occuring and semisynth analgetic opioides

O OHHO

N

Morphine

O OHO

N

Codeinealso against coughslow metabol. to morphine

Small amounts in opium, semisynth from morphine

O OHO

NCH3

O OHHO

NCH3

H3C

OH

pKa=10.0

OH

pKa ca 17

Base

O OHO

NCH3

NH3C CH3

H3C Ph OH

CH3-I

O OHO

NCH3

H3C

CH3-I

O OHO

N

H3C

CH2

CH3

I

O OHOH3C

NCH3

CH3Hoffmanelim

Page 16: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

O OO

NCH3

H3C

OH

Oxycodon (not natural. occur.)

O OHO

NCH3

O OHHO

NCH3

H3CO OO

NCH3

H3C CH3

Thebain Kodein Morfin

H2O2AcOH

O OO

NCH3

H3C

OHH2 / kat.

O OO

NCH3

H3C

OH

Oksykodon

Biosynth.morphine

Page 17: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Total synthetic analgetic opioides

SAR - morphine

Model of morphine bound to-reseptor

O OHHO

NCH3

Must be tert N.N-CH3: agonistN-R (3-4 C, unsat. or ring): antagonistN-R (large): agonist: Ph-CH2CH2 10X more active enn -CH3

OH increase (often)activity

Ether bridge not neccesary

O OHO

NOH

NaloksonAntidote

OHO

NH

OH

Anion

cavity

H-bind acceptor

Lipophilic area

N

OH

O

KetobemidonKetodur®,Ketorax®Ketogan ®

N

N

O

FenantylFenantyl®, Leptanal®(anestetica)N

O

O

in vivo

HN

O

O

CNS eksitering

Petidin (Meperidin)Ketodur®,Ketorax®

Moscow theatre

Morfin

O

OHN

OH

Page 18: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

O

N

OH

O

HO

BuprenorfinTemgesic®, Subutex®

More potent than M. (pain)Partiell -agonist:Antagonister i høye doserNaloxon effects (dysfori etc)

N

O

O

Morfin

O

OHN

OH

DekstropropoksyfenAporex®

(+) most activeless adict. than M.

N

O

-Agonistanalgetc, not euphoria, Long durationGood oral availabil

Metadon

O OHHO

NCH3

OO

Less active -agonist

O OO

N

O O

Heroinincreased BBB penetrationbad -agonist

in vivoO OHO

N

O

bether -agonist than morphine

Page 19: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Biosynthetic routes in Papaver somniferum

Codeine

Noskapin(not analgetic,not adiction)

O OHO

NCH3

O OHHO

NCH3

H3CO OO

NCH3

H3C CH3

Thebaine Morfin

NH

OHHO OH

OH

Norlaudanosoline

NH

OH

OH

HO

HON

O

O

O

O

O O O

N

O

O

O

O

Papaverine(against spasms)

NH2

HO

CO2H

Tyr

Naturally occuring and antitussiva opioides

O OHO

NCH3

O OHHO

NCH3

MorfinKodein

O OHO

NCH3

O OHO

NCH3

NOO OO

NCH3

EtylmorfinCosylan®

HydrokonHydrokon®

FolkodinTuxi®

Page 20: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Alkaloid Natural Products

Quinoline alkaloidsCinchona pubescens (Kinatre) from South America

N

R

HO NH

R=OMe: Quinine (Cinchonidine epimer at C-9)

R=H: Quinidine (Cinchonine epimer at C-9)

Quinidine: AntiarytmicQuinine: Antimalaria

N CF3CF3

HONH

Mefloquine

N Cl

HNN

Chloroquine

Dihydroquini(di)ne and der.Chiral ligandsAsym. dihydroxylation (Sharpless)

Page 21: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Alkaloid Natural Products

Indole alkaloids

NH

HN

MelatoninHormone

MeOO

NH

CO2H

NH2

Tryptophan

Essential amino acid

NH

NH2

SerotoninNeurotransmitter

HO

NH

CO2H

Auxine Plant growth hormone

Psilocybe Mexicana

Psilocybe semilanceata(Spiss fleinsopp)

OR

NH

NHalucinogens from Psilocybe sopper

R=H: PsilocinR=PO3H: Psilocybin

Serotoninagonists, not broken down in the bodystrong, continuos nerve impulse

in vivo

Indole natural products

NHMeO

N

H

H

HMeO2C

O

OOMe

OMe

OMe

OMe

Reserpinefrom Rauwolfia sp.Reduce blood pressure

Rauwolfia serpentinaIndia, Thailand etc

Page 22: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

NH

NH

R'O

RSecale alkaloids and derivativesfrom Claviceps purpurea (meldrøye)

X=H, R'=Me, R=OH: Lysergic acidX=H, R'=Me, R=NEt2: LSD

X=H, R'=Me, R=-NHCH(Et)CH2OH: Metylergometrin, Uterus contractions, drug used after birth

X=Br, R'=Me, R=Bromokriptin, Parlodel®Prolactine inhibitor

X=H, R'=Allyl, R=Kabergolin, Dostinexl ®Prolactine inhibitor

X=H, R'=Me, R=Ergotamin, Anervanel ®Drug against migraine

X

NH

N

O N

O

HO

O

NNH

O

N

NH

N

O N

O

HO

O

Vinca rosea (Catharantus roseus)From MadagaskarPerivinkle

NH

N

HO

MeO2CMeO

NR

N

H OCOMe

CO2MeOH

R=-Me: Vinblastin, Oncovin®R=-CHO: Vinkristin, Velbe ®

Vinca alkaloidsfrom Vinca roseaAnticancer comp.

R

R N

OO

N

H

H

H

H

R= H; StrycnineR=OMe; Brucine (1/50 of S. activity)

Muscle spasms

Strychnos alkaloids - from Strychnos nux vomica

Page 23: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Terpenoide Natural Products

O

Isopentenylpyrophosphate

(C-5)

P PO P P

O

P

OOH

3 ATPOH

HO

OHO

Mevalonate(C-6)

N

N N

N

NH2

OO

OHHO

PO

OHOP

O

OHOP

O

OHHO

ATP, Adenosine-5'-triphosphate

P

O

Isopentenylpyrophosphate

(C-5)

P PRearrange

O

Dimethylallylpyrophosphate

(C-5)

P PO P P

HO

trans-Geranylpyrophosphate

(C-10)

P P

Monoterpenes (C-10)Ex.

OH

Geraniol (+) Limonene

C-10: MonoterpenesC-15: SesquiterpenesC-20: DiterpenesC-25: SesterterpenesC-30: Triterpenes

Page 24: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Monoterpenes Voilatile compds, smell, taste etc.

OH

trans-Geraniol

OH

(-)−β-citronellol (-) Linalool

OH

OH

(+)-α-Terpineol (-)-Menthol

HO

(+)-Carvone

O

OH

Thymol

O

(+) Camphor α-Pinene β-Pinene

The Chiral Pool

PyrethrinesInsecticides from Chrysanthemum cinerariifolium

R

OO

R'

C-10

Cl

ClO

O

O

Synth. analogmore stablemixt of isomers

Permetrin, Nix®

Shampoo, Lice, scabies

C-10

O

H

HOH

Tetrahydrocanabinol

O

O

H

HOH

NabiloneAntiemetic (not reg N.)

Cannabinoids, from Cannabis sativa (Hemp)

Page 25: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Diterpenes (C-20) Isopentenyl-pyrophosphate(C-5)

O P PH

O

trans-Geranylpyrophosphate

(C-10)

P PO

trans, trans-Farnesylpyrophosphate(C-15)

P P

Isopentenyl-pyrophosphate(C-5)

O P PH

SesquiterpenesO

all trans-Geranylgeranylpyrophosphate(C-20)

PP

DiterpenesHO

Phytol

N

NN

N

Mg

O

CO2Me

H

H

H

O

O

Chlorophyll A

Vitamine K1

O

O

Vitaminee E (α-Tocopherol)

O

HO

C-20

Page 26: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Triterpenes (C-20) O

trans, trans-Farnesylpyrophosphate(C-15)

P P OPP+

tail to tail coupling

Squalene (C-30)

O

HO LanosterolH

Squaleneepoxidase

Enzyme-Nu

H

HOH

H

Enz--Nu

H

Squalene epoxide cyclase

(Animals)

H

HO CycloartenolHHO

H

H

Enz--Nu

H

(Plants)

H

HB

B

H

Stereoids

Page 27: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Stereoids

A B

C D1

2

3

45

6

7

8

910

11

1213

14 15

16

17

17β 17α

10β

A / B trans fused

10β

A / B cis fused

B / C og C / D always trans

Cholesterol

Sex hormonesEstrogensProgesteronesTestosteron and anabolic stereoids

CorticoidsGlucocorticostereoids

Cortison etc. etc.Mineralcorticostereoidsr

Aldosterone

Digitalis glycosides

Fucidinic acid (antibiotic)

Brassinostereoids (Plant growth hormones)

etc. etc.

HO Lanosterol(C-30)

H

20 steps

HO

H

H

H

Cholesterol(C-27)

Page 28: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Sex hormones - Estrogenes

HO

H

HH

O

Estrone

in vivo

HO

H

HH

Estradiol

OH

HO

H

HH

Estriol

OH

in vivo

(low activity)

(fast metabol)

OH

(low activity)

Used in drugs

HO

H

HH

OH

H K

2 ekviv.

Ethinyl estradiol(only estrogen im P-pills)

HO

H

HH

Estradiol

OH

HO

OH

DietylstilbøstrolEstrogene agonist, drug before

HO

H

HH

OH

HO

OH

A B

C D

Estrogene agonists (mimics)

(Cl)n

n(Cl)

PCBAlkylphenols

HO

OO

O

O

PhtalatesO

OOH

HO

Genistein(isoflavonoid)

OH

Phytoestrogener(in soya)

Page 29: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Sex hormones - Progesterones (gestagenes, progestrines)

H

HHO

Progesterone

O

MetabolismH

HHHO

HO

Many semisynth drugs in use (better bioavalabil.)

TestosteroneH

HHO

Testosterone

OH

5α-reduktaseH

HHO

5α-Dihydrotestosterone (5DHT)More active A-B ring transCis isomer inaktive

OH

H

H

HO

OH

THG (tetrahydrogestrinon)

H

HO

OH

Gestrinon

Doping - Anabolic stereoidsH

HHO

Testosterone

OH

H

HHO

Epi-testosteronOnly small androgene / anabole activityDifferent biosynt. pathway than T

OH

Normal: T : E ratio ca 6 : 1Doping T: E increases

E added to hide signs of doping

Page 30: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Semisynthesis sex hormones

HO

H

H H

O

O

Diosgenine(6% in Yam roots, Dioscorea sp)

H+

Ac2O

AcO

H

H H

O

AcO

CrO3

AcO

H

H H

OO

O

OR

H+/H2O

AcO

H

H H

O

Key-intermediateEsterhydrol., H2O elim.

AcO

H

H H

O 1)H2 / cat.2) Ester hydrol.

HO

H

H H

O

1) Ox. sec. ROH2) Double bond migr. H

H H

O

O

Progesterone

Hydrocortisone etc

HO

H

H H

O

1) Stereosel .red of ketone (NaBH4) (Attac less hindered side)2) Ox sec. ROH3) Double bond migr. H

H H

OH

O

Testosteron1)red. doublebond2) Ox sec. ROH

H

H H

O

OH

Br2 / AcOH H

H H

O

OH

Br

BrBase(- 2 HBr)

H

H H

O

O

Pyrolysis600 oC

H

H H

O

HOEstrone

Page 31: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Corticostereoids

Mineralcorticoid

O

H

H H

O

OH OOH

AldosteroneRegulation of elektrolyttic ballanceincrease re-uptake of Na (and hence H20)

Glucocorticoid

H

H H

O

O

OH

HO OH

Hydrokortison

Effect on metabolism (karbohydrates, lipids, proteins)Antiinflammatoric

Numerous semisynth. analogs as drugsVarious antiinflam. activity, mineralcorticoid side effects

H

HHO

Progesteron

O

Risopus nigricans

H

HHO

O

HOOks H

HHO

O

ONaBH4 H

HHO

O

HOH

H H

O

O

OH

HO OH

Hydrokortison

Page 32: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Digitalis glycosides (cardenolides)

Digitalis purpurea (foxglowe, revebjelle)

-Treatment of hart disease 1500 BC (Egypt)

-Increase hart contraction

-Tox.

O

OH

OH

OH

CH3

β-D-digitoxose

A-B and C-D cis condens.

DigitoxinDigitoxin® R= H

DigoxinLanoxin® R= OH

H

H OH

R

HO(Digitoxose)3

O O Aglycone: Biolog. activity(KH part; solubility etc..)γ-lactone

αβ

γ

H

H H

H

All trans

H

H

H

H

A-B cis, B-C trans. C-D cisR

R RR

Stability•Acid: Cleavage of sugars (acidic hydro acetals)•Base:

H

H OH

R

HOR

O O

OH

OH

OOHO

OH

OOHO

enolOH

OOO

Aldehyde

taut.Double bond migr,

OO

Hemiacetale

O

HO

OH

H

OO

O

Acetale

Page 33: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

Phenolic Natural Products

Biosynthesis from shikimate (- alkaloides)

CO2H

OHOH

HO

Shikimate

CO2H

HOOH

OH

Gallate

[ox]

O

O

O

P

Phosphoenol-pyruvate

- H2O

CO2H

OOH

Chorismate

CO2 NH

CO2H

NH2

Trp

AlkaloidsRearrange

≈Claisen

OH

Chorismate

HO2C CO2

O

CO2H

OH

NH2

Tyr

Alkaloids

CO2H

NH2

Phe

Alkaloids

CO2

Cinnamate

Page 34: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

From cinnamate

Voilatile compds, smell, taste etc., Not monoterpenes

CO2

CinnamateCinnemal

O

Anetol

OMe

Eugenol

OHOMe

O

Vaniline

OHOMe

OH

Thymol

Monoterpene

CO2

Cinnamate

2

O

OO

OMeOMeMeO

OH

O

Podophyllotoxin

From Podophyllum peltarumMay apple

Antiviral, veneric warts

Toxic - lead for anticancer drugs

O

OO

OHOMeMeO

O

Etoposide

O

O O

HO

HO

Page 35: KJM5230-H04 KJM5230 - Biologisk aktive molekyler Kurset omhandler organisk kjemiske forhold hos sentrale legemiddelgrupper og bioaktive naturstoffer. Emnet

KJM5230-H04

From cinnamate

CO2H CO2H

OH

CO2H

OGlu

OGlu

CO2HO O

Coumarin

O O O

OHOH

O

Dicoumarol-Anticoagulant - Vit K antagonist-Sweet clower disease

O O

OH

O

Warfarin - Marevan®

O

O

R

Vit. K

O O

O

O

OHH

Aflatoxine B1

Aflatoxines-From Aspergillus flavus (fungus)-Attacks nuts etc.-Carcinogenic

OO O

R

R'

R=R'=H: Psoralen

R=H, R'=OMe: Xantotoxin (8-MOP) -

Metoksalen - Geroxalen (R)

Psoralenes-Isolated from various plants-Photochemotherapy against psoriasis-[2+2] cycloadd. Withcytocin / thymin in DNA

OO O

R

R'

HN

N

O

O

OO O

R

R'

HN

N

NNO

O NH2

ONN

NH2

O